-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vfpe/WwoOqatPG8h2bnBClADVrsyz2cRcvLqXPG9Gi135vpfY5Sml6VDv3oLZ4aE e+RKZbpI1ekFE114y5KL8A== 0001144204-10-059792.txt : 20101112 0001144204-10-059792.hdr.sgml : 20101111 20101112160603 ACCESSION NUMBER: 0001144204-10-059792 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100930 FILED AS OF DATE: 20101112 DATE AS OF CHANGE: 20101112 EFFECTIVENESS DATE: 20101112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001346824 IRS NUMBER: 830406777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12884 FILM NUMBER: 101186562 BUSINESS ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 v202261_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2010 Check here if Amendment [_]; Amendment Number: ___________ This Amendment (Check only one): [_] is a restatement. [_] adds new entries. Institutional Investment Manager Filing this Report: Name: RA Capital Management, LLC ------------------------------------- Address: 20 Park Plaza, Suite 905 ------------------------------------- Boston, MA 02116 ------------------------------------- Form 13F File Number: 28-12884 -------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Peter Kolchinsky ------------------------------------- Title: Manager ------------------------------------- Phone: (617) 778-2500 ------------------------------------- Signature, Place, and Date of Signing /s/ Peter Kolchinsky Boston, MA November 12, 2010 - -------------------------- -------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------------- Form 13F Information Tabel Entry Total: 20 ----------------- Form 13F Information Table Value Total: 111,440 ----------------- (thousands) List of Other Included Managers: NONE FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - --------------------------- ------------ ----------- -------- ---------------------- ---------- -------- --------------------- TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE/ SHARED/NONE - ------------------------------------------------------------------------------------------------------------------------------------ AASTROM BIOSCIENCES INC COM NEW 00253U 30 5 2,549 1,644,838 SH SOLE N/A 1,644,838 ALEXION PHARMACEUTICALS INC COM 015351 10 9 9,738 151,300 SH SOLE N/A 151,300 ALLERGAN INC COM 018490 10 2 7,265 109,200 SH SOLE N/A 109,200 ARTHROCARE CORP COM 043136 10 0 10,146 373,292 SH SOLE N/A 373,292 BIOSPECIFICS TECHNOLOGIES CO COM 090931 10 6 16,823 624,917 SH SOLE N/A 624,917 CELGENE CORP COM 151020 10 4 4,874 84,600 SH SOLE N/A 84,600 CUBIST PHARMACEUTICALS INC COM 229678 10 7 4,751 203,100 SH SOLE N/A 203,100 CYPRESS BIOSCIENCES INC COM PAR $.02 232674 50 7 3,850 1,000,000 SH SOLE N/A 1,000,000 DEPOMED INC COM 249908 10 4 5,992 1,337,582 SH SOLE N/A 1,337,582 GENTIUM S P A SPONSORED ADR 37250B 10 4 1,454 202,217 SH SOLE N/A 202,217 JAZZ PHARMACEUTICALS INC COM 472147 10 7 8,237 767,670 SH SOLE N/A 767,670 MAP PHARMACEUTICALS INC COM 56509R 10 8 1,148 75,000 SH SOLE N/A 75,000 NPS PHARMACEUTICALS INC COM 62936P 10 3 684 100,000 SH SOLE N/A 100,000 PHARMASSET INC COM 71715N 10 6 8,400 285,261 SH SOLE N/A 285,261 PSIVIDA CORP COM 74440J 10 1 1,013 231,300 SH SOLE N/A 231,300 SEQUENOM INC COM NEW 817337 40 5 2,454 350,000 SH SOLE N/A 350,000 TARGACEPT INC COM 87611R 30 6 8,566 383,457 SH SOLE N/A 383,457 UNITED THERAPEUTICS CORP DEL COM 91307C 10 2 5,528 98,700 SH SOLE N/A 98,700 VALEANT PHARMACEUTICALS INTL COM 91911X 10 4 7,670 306,200 SH SOLE N/A 306,200 VISION--SCIENCES INC DEL COM 927912 10 5 298 250,679 SH SOLE N/A 250,679
-----END PRIVACY-ENHANCED MESSAGE-----